Brown fat organogenesis and maintenance requires AKT1 and AKT2
- Autores
- Sanchez Gurmaches, Joan; Martinez Calejman, Camila; Jung, Su Myung; Li, Huawei; Guertin, David A.
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Objective: Understanding the signaling mechanisms that control brown adipose tissue (BAT) development is relevant to understanding energy homeostasis and obesity. The AKT kinases are insulin effectors with critical in vivo functions in adipocytes; however, their role in adipocyte development remains poorly understood. The goal of this study was to investigate AKT function in BAT development. Methods: We conditionally deleted Akt1 and Akt2 either individually or together with Myf5-Cre, which targets early mesenchymal precursors that give rise to brown adipocytes. Because Myf5-Cre also targets skeletal muscle and some white adipocyte lineages, comparisons were made between AKT function in BAT versus white adipose tissue (WAT) and muscle development. We also deleted both Akt1 and Akt2 in mature brown adipocytes with Ucp1-Cre or Ucp1-CreER to investigate AKT1/2 signaling in BAT maintenance. Results: AKT1 and AKT2 are individually dispensable in Myf5-Cre lineages in vivo for establishing brown and white adipocyte precursor cell pools and for their ability to differentiate (i.e. induce PPARγ). AKT1 and AKT2 are also dispensable for skeletal muscle development, and AKT3 does not compensate in either the adipocyte or muscle lineages. In contrast, AKT2 is required for adipocyte lipid filling and efficient downstream AKT substrate phosphorylation. Mice in which both Akt1 and Akt2 are deleted with Myf5-Cre lack BAT but have normal muscle mass, and doubly deleting Akt1 and Akt2 in mature brown adipocytes, either congenitally (with Ucp1-Cre), or inducibly in older mice (with Ucp1-CreER), also ablates BAT. Mechanistically, AKT signaling promotes adipogenesis in part by stimulating ChREBP activity. Conclusions: AKT signaling is required in vivo for BAT development but dispensable for skeletal muscle development. AKT1 and AKT2 have both overlapping and distinct functions in BAT development with AKT2 being the most critical individual isoform. AKT1 and AKT2 also have distinct and complementary functions in BAT maintenance.
Fil: Sanchez Gurmaches, Joan. University Of Cincinnati College Of Medicine; Estados Unidos. University of Massachusetts Medical School; Estados Unidos
Fil: Martinez Calejman, Camila. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina
Fil: Jung, Su Myung. University Of Massachusetts Medical School; Estados Unidos
Fil: Li, Huawei. University Of Massachusetts Medical School; Estados Unidos
Fil: Guertin, David A.. University Of Massachusetts Medical School; Estados Unidos - Materia
-
ADIPOGENESIS
AKT
BROWN ADIPOSE TISSUE
DEVELOPMENT
INSULIN SIGNALING
LIPODYSTROPHY
MTORC2
OBESITY
WHITE ADIPOSE TISSUE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/163797
Ver los metadatos del registro completo
id |
CONICETDig_5badb50ae19b5cd4d29d77bcd72960b1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/163797 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Brown fat organogenesis and maintenance requires AKT1 and AKT2Sanchez Gurmaches, JoanMartinez Calejman, CamilaJung, Su MyungLi, HuaweiGuertin, David A.ADIPOGENESISAKTBROWN ADIPOSE TISSUEDEVELOPMENTINSULIN SIGNALINGLIPODYSTROPHYMTORC2OBESITYWHITE ADIPOSE TISSUEhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Objective: Understanding the signaling mechanisms that control brown adipose tissue (BAT) development is relevant to understanding energy homeostasis and obesity. The AKT kinases are insulin effectors with critical in vivo functions in adipocytes; however, their role in adipocyte development remains poorly understood. The goal of this study was to investigate AKT function in BAT development. Methods: We conditionally deleted Akt1 and Akt2 either individually or together with Myf5-Cre, which targets early mesenchymal precursors that give rise to brown adipocytes. Because Myf5-Cre also targets skeletal muscle and some white adipocyte lineages, comparisons were made between AKT function in BAT versus white adipose tissue (WAT) and muscle development. We also deleted both Akt1 and Akt2 in mature brown adipocytes with Ucp1-Cre or Ucp1-CreER to investigate AKT1/2 signaling in BAT maintenance. Results: AKT1 and AKT2 are individually dispensable in Myf5-Cre lineages in vivo for establishing brown and white adipocyte precursor cell pools and for their ability to differentiate (i.e. induce PPARγ). AKT1 and AKT2 are also dispensable for skeletal muscle development, and AKT3 does not compensate in either the adipocyte or muscle lineages. In contrast, AKT2 is required for adipocyte lipid filling and efficient downstream AKT substrate phosphorylation. Mice in which both Akt1 and Akt2 are deleted with Myf5-Cre lack BAT but have normal muscle mass, and doubly deleting Akt1 and Akt2 in mature brown adipocytes, either congenitally (with Ucp1-Cre), or inducibly in older mice (with Ucp1-CreER), also ablates BAT. Mechanistically, AKT signaling promotes adipogenesis in part by stimulating ChREBP activity. Conclusions: AKT signaling is required in vivo for BAT development but dispensable for skeletal muscle development. AKT1 and AKT2 have both overlapping and distinct functions in BAT development with AKT2 being the most critical individual isoform. AKT1 and AKT2 also have distinct and complementary functions in BAT maintenance.Fil: Sanchez Gurmaches, Joan. University Of Cincinnati College Of Medicine; Estados Unidos. University of Massachusetts Medical School; Estados UnidosFil: Martinez Calejman, Camila. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaFil: Jung, Su Myung. University Of Massachusetts Medical School; Estados UnidosFil: Li, Huawei. University Of Massachusetts Medical School; Estados UnidosFil: Guertin, David A.. University Of Massachusetts Medical School; Estados UnidosElsevier Gmbh2019-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/163797Sanchez Gurmaches, Joan; Martinez Calejman, Camila; Jung, Su Myung; Li, Huawei; Guertin, David A.; Brown fat organogenesis and maintenance requires AKT1 and AKT2; Elsevier Gmbh; Molecular Metabolism; 23; 5-2019; 60-742212-8778CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.molmet.2019.02.004info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2212877818300607info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:48:49Zoai:ri.conicet.gov.ar:11336/163797instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:48:49.934CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
title |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
spellingShingle |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 Sanchez Gurmaches, Joan ADIPOGENESIS AKT BROWN ADIPOSE TISSUE DEVELOPMENT INSULIN SIGNALING LIPODYSTROPHY MTORC2 OBESITY WHITE ADIPOSE TISSUE |
title_short |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
title_full |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
title_fullStr |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
title_full_unstemmed |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
title_sort |
Brown fat organogenesis and maintenance requires AKT1 and AKT2 |
dc.creator.none.fl_str_mv |
Sanchez Gurmaches, Joan Martinez Calejman, Camila Jung, Su Myung Li, Huawei Guertin, David A. |
author |
Sanchez Gurmaches, Joan |
author_facet |
Sanchez Gurmaches, Joan Martinez Calejman, Camila Jung, Su Myung Li, Huawei Guertin, David A. |
author_role |
author |
author2 |
Martinez Calejman, Camila Jung, Su Myung Li, Huawei Guertin, David A. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
ADIPOGENESIS AKT BROWN ADIPOSE TISSUE DEVELOPMENT INSULIN SIGNALING LIPODYSTROPHY MTORC2 OBESITY WHITE ADIPOSE TISSUE |
topic |
ADIPOGENESIS AKT BROWN ADIPOSE TISSUE DEVELOPMENT INSULIN SIGNALING LIPODYSTROPHY MTORC2 OBESITY WHITE ADIPOSE TISSUE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Objective: Understanding the signaling mechanisms that control brown adipose tissue (BAT) development is relevant to understanding energy homeostasis and obesity. The AKT kinases are insulin effectors with critical in vivo functions in adipocytes; however, their role in adipocyte development remains poorly understood. The goal of this study was to investigate AKT function in BAT development. Methods: We conditionally deleted Akt1 and Akt2 either individually or together with Myf5-Cre, which targets early mesenchymal precursors that give rise to brown adipocytes. Because Myf5-Cre also targets skeletal muscle and some white adipocyte lineages, comparisons were made between AKT function in BAT versus white adipose tissue (WAT) and muscle development. We also deleted both Akt1 and Akt2 in mature brown adipocytes with Ucp1-Cre or Ucp1-CreER to investigate AKT1/2 signaling in BAT maintenance. Results: AKT1 and AKT2 are individually dispensable in Myf5-Cre lineages in vivo for establishing brown and white adipocyte precursor cell pools and for their ability to differentiate (i.e. induce PPARγ). AKT1 and AKT2 are also dispensable for skeletal muscle development, and AKT3 does not compensate in either the adipocyte or muscle lineages. In contrast, AKT2 is required for adipocyte lipid filling and efficient downstream AKT substrate phosphorylation. Mice in which both Akt1 and Akt2 are deleted with Myf5-Cre lack BAT but have normal muscle mass, and doubly deleting Akt1 and Akt2 in mature brown adipocytes, either congenitally (with Ucp1-Cre), or inducibly in older mice (with Ucp1-CreER), also ablates BAT. Mechanistically, AKT signaling promotes adipogenesis in part by stimulating ChREBP activity. Conclusions: AKT signaling is required in vivo for BAT development but dispensable for skeletal muscle development. AKT1 and AKT2 have both overlapping and distinct functions in BAT development with AKT2 being the most critical individual isoform. AKT1 and AKT2 also have distinct and complementary functions in BAT maintenance. Fil: Sanchez Gurmaches, Joan. University Of Cincinnati College Of Medicine; Estados Unidos. University of Massachusetts Medical School; Estados Unidos Fil: Martinez Calejman, Camila. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina Fil: Jung, Su Myung. University Of Massachusetts Medical School; Estados Unidos Fil: Li, Huawei. University Of Massachusetts Medical School; Estados Unidos Fil: Guertin, David A.. University Of Massachusetts Medical School; Estados Unidos |
description |
Objective: Understanding the signaling mechanisms that control brown adipose tissue (BAT) development is relevant to understanding energy homeostasis and obesity. The AKT kinases are insulin effectors with critical in vivo functions in adipocytes; however, their role in adipocyte development remains poorly understood. The goal of this study was to investigate AKT function in BAT development. Methods: We conditionally deleted Akt1 and Akt2 either individually or together with Myf5-Cre, which targets early mesenchymal precursors that give rise to brown adipocytes. Because Myf5-Cre also targets skeletal muscle and some white adipocyte lineages, comparisons were made between AKT function in BAT versus white adipose tissue (WAT) and muscle development. We also deleted both Akt1 and Akt2 in mature brown adipocytes with Ucp1-Cre or Ucp1-CreER to investigate AKT1/2 signaling in BAT maintenance. Results: AKT1 and AKT2 are individually dispensable in Myf5-Cre lineages in vivo for establishing brown and white adipocyte precursor cell pools and for their ability to differentiate (i.e. induce PPARγ). AKT1 and AKT2 are also dispensable for skeletal muscle development, and AKT3 does not compensate in either the adipocyte or muscle lineages. In contrast, AKT2 is required for adipocyte lipid filling and efficient downstream AKT substrate phosphorylation. Mice in which both Akt1 and Akt2 are deleted with Myf5-Cre lack BAT but have normal muscle mass, and doubly deleting Akt1 and Akt2 in mature brown adipocytes, either congenitally (with Ucp1-Cre), or inducibly in older mice (with Ucp1-CreER), also ablates BAT. Mechanistically, AKT signaling promotes adipogenesis in part by stimulating ChREBP activity. Conclusions: AKT signaling is required in vivo for BAT development but dispensable for skeletal muscle development. AKT1 and AKT2 have both overlapping and distinct functions in BAT development with AKT2 being the most critical individual isoform. AKT1 and AKT2 also have distinct and complementary functions in BAT maintenance. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/163797 Sanchez Gurmaches, Joan; Martinez Calejman, Camila; Jung, Su Myung; Li, Huawei; Guertin, David A.; Brown fat organogenesis and maintenance requires AKT1 and AKT2; Elsevier Gmbh; Molecular Metabolism; 23; 5-2019; 60-74 2212-8778 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/163797 |
identifier_str_mv |
Sanchez Gurmaches, Joan; Martinez Calejman, Camila; Jung, Su Myung; Li, Huawei; Guertin, David A.; Brown fat organogenesis and maintenance requires AKT1 and AKT2; Elsevier Gmbh; Molecular Metabolism; 23; 5-2019; 60-74 2212-8778 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.molmet.2019.02.004 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2212877818300607 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Gmbh |
publisher.none.fl_str_mv |
Elsevier Gmbh |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268942077263872 |
score |
13.13397 |